Replies to post #173638 on NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Longfellow, good post. So why doesn't LP just say so. It is not betraying any confidences, but saying why they continue with the trial. That would allay much of the speculation and pushing for unblinding this trial prematurely. Complete silence is not the answer. Unfulfilled deliveries, e.g., 90 day investigation, publication, etc. do not engender support. They got their vote, their bonus shares, so where is the payback in a little communication? Les told a number of investors, first the vote and then shortly thereafter the pub. Its been a month and just crickets.

[marzan]

lf, I think with RTT act passed, revenue will start pouring in for D as well as for L, as they both cover all operable and inoperable solid tumors which covers 90% of the cancers in the world. Yes, L will treat not just GBM but all operable solid tumors. I expect greater demand for D and L than any other RTT therapies possibly accessed by the patients. I think the only therapy that will see the maximum benefit of this implementation of RTT act is DCVax platform. Media will compete for patients' success stories and will cover all the marketing expenses free for us, imo. This will assure LP to get the maximum out of the L trial taking it blinded to 80% OS events. no problem for shareholders, imo. Knowing L, hope Susan opts for L kicking off the RTT.